Skip to main content

Table 1 Characteristics of the 452 patients with three 2D shear wave elastography (SWE) measurements

From: 2D-shear wave elastography: number of acquisitions can be reduced according to clinical setting

  N = 452
Age (years) ± SD (missing N = 29) 49.0 ± 13.5
Gender M/F (missing N = 18) 282(65%)/152(35%)
BMI (kg/m2) ± SD (missing N = 201) 26.3 ± 5.6
< 25 kg/m2 115 (46%)
25–29.9 kg/m2 81 (32%)
≥ 30 kg/m2 55 (22%)
ALD 62 (14%)
HBV 108 (24%)
HCV 116 (26%)
NAFLD 69 (15%)
Other 97 (21%)
2D-SWE registration—Biopsy delay (days) median (IQR) 0 (0; 2)
Mean LS of three 2D-SWE measures (kPa) median (IQR) 9 (6.8; 21.4)
Fibrosis stage
 F0 72 (15.9%)
 F1 103 (22.8%)
 F2 72 (15.9%)
 F3 54 (12.0%)
 F4 151 (33.4%)
Steatosis grade (missing N = 149)
 S0 140 (46%)
 S1 82 (27%)
 S2 60 (20%)
 S3 21 (7%)
AST (IU/L) (missing N = 55) median (IQR) 48 (32; 69)
ALT (IU/L) (missing N = 36) median (IQR) 52 (32; 85)
Total bilirubin (µmol/L) (missing N = 48) median (IQR) 13 (8.6; 23.9)
  1. 2D-SWE two dimensional—shear wave elastography, ALD alcohol-related liver disease, AST aspartate aminotransferase, BMI body mass index, CLD chronic liver disease, HBV hepatitis B virus, HCV hepatitis C virus, IQR interquartile range, LS liver stiffness, NAFLD nonalcoholic fatty liver disease, SD standard deviation. Data are expressed as numbers (%), means (SD) or medians (IQR) as appropriate